Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Intervax Biologicals is a Canadian biopharmaceutical company that specializes in the international supply and distribution of essential vaccines, most notably the Bacillus Calmette-Guérin (BCG) vaccine. The company serves as a vital link in the global health supply chain, providing vaccines for the prevention of tuberculosis and the treatment of non-muscle invasive bladder cancer. Intervax maintains strategic partnerships with international procurement agencies such as UNICEF and the Pan American Health Organization (PAHO) to ensure vaccine accessibility in diverse markets. Their portfolio is focused on high-impact public health products, leveraging a robust network of manufacturing partners to meet global demand. The company is recognized for its expertise in navigating the regulatory and logistical complexities of biological product distribution. By managing the supply of critical immunotherapies and vaccines, Intervax addresses global shortages and supports national immunization programs worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Intervax.